2027 ICD-10-CM Diagnosis Code T42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter

ICD-10-CM Codes›S00–T88›T36-T50›T42

ICD-10-CM T42.6X5A
CMSSource: CMS FY 2027 ICD-10-CM dataset · Effective Oct 1, 2026 – Sep 30, 2027

T42.6X5A is a billable ICD-10-CM diagnosis code for adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2027 (October 1, 2026 through September 30, 2027) and groups to MS-DRG 791, 793, 917 through 918. The code is not accepted as a principal diagnosis by the Medicare Code Editor. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Adverse effects of drugs and medicaments, initial encounter; and Sedative-related disorders.

Code Identity

ICD-10-CM Code
T42.6X5A
Billable Status
Yes — Valid for Submission
Code Describes
Adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter
Short Description
Adverse effect of antiepileptic and sed-hypntc drugs, init
Parent Code
Adverse effect of other antiepileptic and sedative-hypnotic drugs

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT42Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs
This CodeT42.6X5AAdverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter

Code EditsBilling

Medicare Code Editor checks that affect claim validity for T42.6X5A.

There are selected codes that describe a circumstance which influences an individual's health status but not a current illness or injury, or codes that are not specific manifestations but may be due to an underlying cause. These codes are considered unacceptable as a principal diagnosis.

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Acne of external chemical origin
  • Acneiform eruption
  • Acneiform eruption caused by chemical
  • Acneiform eruption due to bromine compound
  • Acute metabolic acidosis
  • Adverse reaction caused by bromine and/or bromine compound
  • Adverse reaction caused by valproic acid
  • Adverse reaction to aldehyde
  • Adverse reaction to carbromal
  • Adverse reaction to chloral and/or chloral derivative
  • Adverse reaction to glutethimide
  • Adverse reaction to methaqualone
  • Anticonvulsant drug-induced osteomalacia
  • Barbiturate antiepileptic adverse reaction
  • Beclamide adverse reaction
  • Bromine acne
  • Bromoderma
  • Carbamate sedative adverse reaction
  • Chloral hydrate adverse reaction
  • Chlormethiazole adverse reaction
  • Chlormezanone adverse reaction
  • Congenital malformation caused by valproic acid
  • Fetal disorder caused by anticonvulsant via placental transfer
  • Fetal valproate syndrome
  • Gabapentin adverse reaction
  • Halogen acne
  • Halogen eruption
  • Lamotrigine adverse reaction
  • Metabolic acidosis caused by paraldehyde
  • Methyprylone adverse reaction
  • Osteomalacia secondary to drug
  • Paraldehyde adverse reaction
  • Piracetam adverse reaction
  • Primidone adverse reaction
  • Propionic acid derivative adverse reaction
  • Sodium valproate adverse reaction
  • Triclofos sodium adverse reaction
  • Vigabatrin adverse reaction
  • Zolpidem adverse reaction
  • Zopiclone adverse reaction

Coding GuidelinesGuidance

When coding an adverse effect of a drug that has been correctly prescribed and properly administered, assign the appropriate code for the nature of the adverse effect followed by the appropriate code for the adverse effect of the drug.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs (T42). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2027, published by CMS and the National Center for Health Statistics.

Instructional NotesGuidance

Instructions from the official ICD-10-CM Tabular List that apply to T42.6X5A: its own notes plus those printed at T42.6, T42, block T36-T50, and Chapter 19. A note printed at a category, block or chapter applies to every code under it.

Includes

Further defines, or gives examples of, the content of the category.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • adverse effect of correct substance properly administered
  • poisoning by overdose of substance
  • poisoning by wrong substance given or taken in error
  • underdosing by (inadvertently) (deliberately) taking less substance than prescribed or instructed

Excludes1

Not coded here: the excluded code is never reported together with this one, unless the two conditions are unrelated.

From T42.6 Poisoning by, adverse effect of and underdosing of other antiepileptic and sedative-hypnotic drugs applies to 18 codes
  • poisoning by, adverse effect of and underdosing of carbamazepine (T42.1-)
From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • toxic reaction to local anesthesia in pregnancy (O29.3-)

Excludes2

Not included here: the excluded condition is not part of this code, but a patient may have both, so both codes may be reported.

From T42 Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs applies to 162 codes
  • drug dependence and related mental and behavioral disorders due to psychoactive substance use (F10.--F19.-)
From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • abuse and dependence of psychoactive substances (F10-F19)
  • abuse of non-dependence-producing substances (F55.-)
  • immunodeficiency due to drugs (D84.821)
  • drug reaction and poisoning affecting newborn (P00-P96)
  • pathological drug intoxication (inebriation) (F10-F19)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes

Code First

The underlying condition named in the note is sequenced before this code.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • for adverse effects, the nature of the adverse effect, such as:
  • adverse effect NOS (T88.7)
  • aspirin gastritis (K29.-)
  • blood disorders (D56-D76)
  • contact dermatitis (L23-L25)
  • dermatitis due to substances taken internally (L27.-)
  • nephropathy (N14.0-N14.2)

Use Additional Code

Add a second code, after this one, to fully describe the condition.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • code(s) to specify:
  • manifestations of poisoning
  • underdosing or failure in dosage during medical and surgical care (Y63.6, Y63.8-Y63.9)
  • underdosing of medication regimen (Z91.12-, Z91.13-)
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • code to identify any retained foreign body, if applicable (Z18.-)

Notes

General instructions on how these codes are used.

From Block T36-T50 Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances applies to 3,186 codes
  • The drug giving rise to the adverse effect should be identified by use of codes from categories T36-T50 with fifth or sixth character 5.
From Chapter 19 (S00-T88) Injury, poisoning and certain other consequences of external causes applies to 41,187 codes
  • Use secondary code(s) from Chapter 20, External causes of morbidity, to indicate cause of injury. Codes within the T section that include the external cause do not require an additional external cause code
  • The chapter uses the S-section for coding different types of injuries related to single body regions and the T-section to cover injuries to unspecified body regions as well as poisoning and certain other consequences of external causes.

7th Character

Every code in the category takes a 7th character from the listed values, with the placeholder X filling any empty positions before it.

From T42 Poisoning by, adverse effect of and underdosing of antiepileptic, sedative- hypnotic and antiparkinsonism drugs applies to 162 codes
  • The appropriate 7th character is to be added to each code from category T42
  • Ainitial encounter this code
  • Dsubsequent encounter
  • Ssequela

Source: CMS ICD-10-CM Tabular List. How to read instructional notes.

Referenced in Other NotesGuidance

Instructional notes printed at other codes that name T42.6X5A, its category, or a range that includes it.

Excludes2 2

These codes carry an Excludes2 note naming T42.6X5A: its condition is not part of those codes, and both may be reported when the patient has both.

  • F13.2 Sedative, hypnotic or anxiolytic-related dependence
    sedative, hypnotic, or anxiolytic poisoning (T42.-) names T42.-, which includes this code
  • T43 Poisoning by, adverse effect of and underdosing of psychotropic drugs, not elsewhere classified
    methaqualone (T42.6-) names T42.6-, which includes this code

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR INJ028
Adverse effects of drugs and medicaments, initial encounter
Default principal diagnosis: inpatient No · outpatient Yes
CCSR MBD020
Sedative-related disorders
Default principal diagnosis: inpatient No · outpatient No

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect
Under­dosing
AcecarbromalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
AcetylcarbromalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
AcetylpheneturideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
AllylisopropylacetylureaT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
AllyltribromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Ammonium::bromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Anticonvulsant::hypnotic NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Anticonvulsant::pyrimidinedioneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Anticonvulsant::specified NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Antiepilepsy agent::specified, NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ApronalideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
AvomineT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BarbexacloneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BeclamideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Beta-ChlorT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Bromal (hydrate)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Bromide saltsT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Bromine::compounds (medicinal)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Bromine::sedativeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BromisovalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BromisovalumT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BromoformT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BromuralT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
BromvaletoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Butyl::chloral (hydrate)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Butylchloral hydrateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Calcium::bromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Calcium::bromolactobionateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Carbamate (sedative)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
CarbromalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::bromidesT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::chloral hydrateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::hypnotics::specified NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::paraldehydeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::sedatives; sedative-hypnotics::mixed NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Central nervous system::depressants::sedatives; sedative-hypnotics::specified NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChloralT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Chloral::derivativeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Chloral::hydrateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChloralamideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChloralodolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChlorbutolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChlorethiazolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChloretoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChlorhexadolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChlormethiazoleT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ChlormezanoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ClomethiazoleT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Cloral betaineT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Croton (oil)::chloralT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
DichloralphenozoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Diethylsulfone-diethylmethaneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
DivalproexT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
DoridenT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
DormisonT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
EctylureaT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
EthchlorvynolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
EthinamateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
EtifoxineT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
GlutethimideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
HexapropymateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Hypnotic::specified NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Lactuca (virosa) (extract)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
LactucariumT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Lettuce opiumT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
LevanilT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
LevopromeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
MeparfynolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Methaqualone (compound)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Methyl::parafynolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Methyl::sulfonalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
MethylparafynolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Methylpentynol, methylpenthynolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
MethyprylonT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
NiaprazineT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
NoctecT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
NoludarT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ParacetaldehydeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ParaldehydeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Pentaerythritol::chloralT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PericlorT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PetrichloralT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PhenacemideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PhenerganT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PheneturideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PhthalimidoglutarimideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PlacidylT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Potassium (salts) NEC::bromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PrimidoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ProgabideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Propionaldehyde (medicinal)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
PyrithyldioneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
QuaaludeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Sedative NEC::mixed NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SedormidT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SerenesilT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Sodium::bromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Sodium::valproateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SomnosT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SoporT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Soporific drug::specified type NECT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SulfonalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SulfonethylmethaneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SulfonmethaneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SulthiameT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
SultiameT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TetronalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ToloxatoneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Tranquilizer NEC::with hypnotic or sedativeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TribromacetaldehydeT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TribromomethaneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TrichloroethanolT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Trichloroethyl phosphateT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TriclofosT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
TrionalT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Triple::bromidesT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Valerian::rootT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Valerian::tinctureT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ValmidT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ValnoctamideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Valproate (sodium)T42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
Valproic acidT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ValpromideT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
VigabatrinT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
WelldormT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ZolpidemT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6
ZopicloneT42.6X1T42.6X2T42.6X3T42.6X4T42.6X5T42.6X6

Patient EducationClinical

Drug Reactions

Most of the time, medicines make our lives better. They reduce aches and pains, fight infections, and control problems such as high blood pressure or diabetes. But medicines can also cause unwanted reactions, such as drug interactions, side effects, and allergies.

The full article covers:

  • What is a drug interaction?
  • What are side effects?
  • What are drug allergies?
  • How can I stay safe when taking medicines?

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T42.6X5A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
995.29 Adv eff med/biol NEC/NOS
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E936.3 Adv eff antconvl NEC/NOS
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
995.29 Adv eff med/biol NEC/NOS
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E937.8 Adv eff sedat/hypnot NEC
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2026No changes
FY 2027CurrentCurrent code set, no changesEffective October 1, 2026 through September 30, 2027.

Questions About T42.6X5AOverview

Is T42.6X5A a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter on HIPAA-covered claims from October 1, 2026 through September 30, 2027.

What does the 7th character A in T42.6X5A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for adverse effect of other antiepileptic and sedative-hypnotic drugs, such as an emergency visit or first evaluation.

What MS-DRG does T42.6X5A group to?

On inpatient claims, adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter maps to MS-DRG 793, 791, 918, 917, with relative weights from 0.8716 to 4.2192 depending on complications. Higher weights mean higher Medicare reimbursement.

Can T42.6X5A be a principal diagnosis?

No. The Medicare Code Editor rejects this code as a principal diagnosis because adverse effect of other antiepileptic and sedative-hypnotic drugs, initial encounter describes a circumstance that influences health status rather than a current illness. Report it as a secondary diagnosis.

Can T42.6X5A be reported with a code from T42.1?

Not as a rule. The Excludes1 note at T42.6, which applies to T42.6X5A, lists "poisoning by, adverse effect of and underdosing of carbamazepine (T42.1-)". An Excludes1 note means the excluded code is never reported together with this one; the only exception is when the two conditions are unrelated to each other (Official Guidelines, Section I.A.12.a).